Company
Calistoga
- Business model
- B2B
Claim, correct or request removal
Record updated 28 September 2026
About
Calistoga was recently acquired by Gilead Pharmaceuticals for total proceeds of up to $600 Million. The company was a cancer pharmaceutical company developing cancer treatments targeting PI3 Kinase.
Loading relationship preview